Wednesday, September 19, 2018 7:42:46 PM
Aurora Cannabis to Issue Return of Capital to Shareholders via Spin-Out of U.S. Assets
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES/
New Spin-Off Company Australis Capital Applying for CSE Listing
TSX: ACB
EDMONTON, June 20, 2018 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) announced today that it intends to distribute units consisting of shares and warrants of its subsidiary, Australis Capital Inc. ("Australis"), to shareholders of the Company by way of a return of capital.
Capital distribution of Australis shares to Aurora shareholders
The spin-out of Australis will happen in the form of a distribution of units (the "Units") in Australis Capital to resident holders of Aurora shares (the "Distribution"). Non-resident holders will receive cash instead of units pursuant to the spin-out, as explained below.
The Distribution will be paid on the basis of one Unit for every 20 Aurora shares outstanding on the record date, to be fixed by the board of directors of Aurora. Each Unit will consist of one common share ("Share") and one Share purchase warrant ("Warrant") of Australis. Each Warrant will entitle the holder thereof to acquire one Share at an exercise price of $0.25 per Australis share, on or prior to 4:00 p.m. (Eastern Time) on the date that is one year from the date of the Distribution.
Aurora shareholders are not required to pay for the Units they receive by way of the Distribution, to tender or surrender their Aurora shares, or to take any other action in connection with the Distribution, other than providing a declaration of residency.
Australis has filed a preliminary prospectus in all provinces and territories of Canada, except for Quebec in respect of the Distribution, which is available on SEDAR under Australis' profile (www.sedar.com). Australis intends to file a preliminary prospectus in Quebec shortly, upon completion of translation of the preliminary prospectus into French.
Spin-out to Non-resident Holders
As described in further detail in the preliminary prospectus, no Shares will be issued to shareholders who are (or are deemed to be) non-residents of Canada. Rather, such Shares will be delivered to a custodian for sale in the open market following the Distribution, and the net cash proceeds will be delivered to non-resident shareholders, net of any withholding taxes. Shareholders who fail to provide a declaration of Canadian residency in the form that will be provided will be deemed to be a non-resident for these purposes. Canadian shareholders who hold their shares in Aurora through a brokerage or other account are therefore urged to contact their brokers to avoid being deemed a non-resident.
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES/
New Spin-Off Company Australis Capital Applying for CSE Listing
TSX: ACB
EDMONTON, June 20, 2018 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) announced today that it intends to distribute units consisting of shares and warrants of its subsidiary, Australis Capital Inc. ("Australis"), to shareholders of the Company by way of a return of capital.
Capital distribution of Australis shares to Aurora shareholders
The spin-out of Australis will happen in the form of a distribution of units (the "Units") in Australis Capital to resident holders of Aurora shares (the "Distribution"). Non-resident holders will receive cash instead of units pursuant to the spin-out, as explained below.
The Distribution will be paid on the basis of one Unit for every 20 Aurora shares outstanding on the record date, to be fixed by the board of directors of Aurora. Each Unit will consist of one common share ("Share") and one Share purchase warrant ("Warrant") of Australis. Each Warrant will entitle the holder thereof to acquire one Share at an exercise price of $0.25 per Australis share, on or prior to 4:00 p.m. (Eastern Time) on the date that is one year from the date of the Distribution.
Aurora shareholders are not required to pay for the Units they receive by way of the Distribution, to tender or surrender their Aurora shares, or to take any other action in connection with the Distribution, other than providing a declaration of residency.
Australis has filed a preliminary prospectus in all provinces and territories of Canada, except for Quebec in respect of the Distribution, which is available on SEDAR under Australis' profile (www.sedar.com). Australis intends to file a preliminary prospectus in Quebec shortly, upon completion of translation of the preliminary prospectus into French.
Spin-out to Non-resident Holders
As described in further detail in the preliminary prospectus, no Shares will be issued to shareholders who are (or are deemed to be) non-residents of Canada. Rather, such Shares will be delivered to a custodian for sale in the open market following the Distribution, and the net cash proceeds will be delivered to non-resident shareholders, net of any withholding taxes. Shareholders who fail to provide a declaration of Canadian residency in the form that will be provided will be deemed to be a non-resident for these purposes. Canadian shareholders who hold their shares in Aurora through a brokerage or other account are therefore urged to contact their brokers to avoid being deemed a non-resident.
Recent ACB News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/28/2026 12:15:03 PM
- Aurora Advances Global Medical Cannabis Portfolio with New Product Launches Across Key International Markets • PR Newswire (Canada) • 04/28/2026 10:53:00 AM
- Aurora Advances Global Medical Cannabis Portfolio with New Product Launches Across Key International Markets • PR Newswire (US) • 04/28/2026 10:53:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/16/2026 08:18:36 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/15/2026 11:21:53 AM
- Aurora Cannabis Accelerates Global Medical Cannabis Leadership with Accretive Acquisition of Safari Flower Company, Expanding EU GMP Capacity to Serve Growing High Margin International Markets • PR Newswire (Canada) • 04/15/2026 11:05:00 AM
- Aurora Cannabis Accelerates Global Medical Cannabis Leadership with Accretive Acquisition of Safari Flower Company, Expanding EU GMP Capacity to Serve Growing High Margin International Markets • PR Newswire (US) • 04/15/2026 11:05:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/30/2026 11:29:57 AM
- Aurora Recognized for Executive Gender Diversity by the Globe & Mail for Second Consecutive Year • PR Newswire (US) • 03/30/2026 11:03:00 AM
- Aurora Recognized for Executive Gender Diversity by the Globe & Mail for Second Consecutive Year • PR Newswire (Canada) • 03/30/2026 11:03:00 AM
- Aurora to Participate in the TD Cowen 46th Annual Health Care Conference • PR Newswire (US) • 02/17/2026 11:39:00 PM
- Aurora to Participate in the TD Cowen 46th Annual Health Care Conference • PR Newswire (Canada) • 02/17/2026 11:39:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/12/2026 09:26:03 PM
- Aurora to Ring the Nasdaq Closing Bell on Wednesday, February 18, 2026, Reinforcing Strategic Focus on Global Medical Cannabis • PR Newswire (US) • 02/12/2026 09:05:00 PM
- Aurora to Ring the Nasdaq Closing Bell on Wednesday, February 18, 2026, Reinforcing Strategic Focus on Global Medical Cannabis • PR Newswire (Canada) • 02/12/2026 09:05:00 PM
- Aurora Advances Global Medical Growth Strategy with Portfolio Expansion in Australia & New Zealand • PR Newswire (Canada) • 02/11/2026 12:00:00 PM
- Aurora Advances Global Medical Growth Strategy with Portfolio Expansion in Australia & New Zealand • PR Newswire (US) • 02/11/2026 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/04/2026 09:44:28 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/04/2026 02:45:22 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/04/2026 12:27:19 PM
- Form SUPPL - Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] • Edgar (US Regulatory) • 02/04/2026 12:10:54 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/04/2026 12:05:38 PM
- Aurora Cannabis Announces Filing of Prospectus Supplement for At-The-Market Offering Program • PR Newswire (Canada) • 02/04/2026 12:00:00 PM
- Aurora Cannabis Announces Fiscal 2026 Third Quarter Results • PR Newswire (Canada) • 02/04/2026 12:00:00 PM
- Aurora Cannabis Announces Fiscal 2026 Third Quarter Results • PR Newswire (US) • 02/04/2026 12:00:00 PM
